References
- de Boer A. C., Han P., Turpie A. G.G., Butt R., Gent M., Genton E. Platelet tests and anti-platelet drugs in coronary artery disease. Circulation 1983; 67: 500
- Born G. V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927
- Cardinal D. C., Flower R. J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J. Pharmacol. Meth. 1980; 3: 135
- Frojmovic M. M., Milton J. G., Duchastel A. Microscopic measuring of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation. J. Lab. din. Med. 1983; 101: 964
- Hanley S. P., Bevan J., Cockbill S. R., Heptinstall S. A regimen for low-dose aspirin?. Br. med. J. 1982; 285: 1299
- Holdrinet A., Ewals M., Haanen C. A simple test for measuring platelet aggregation. Thromb. Diath. Haemorrh. 1969; 22: 174
- Hoogendijk E. M.G., ten Cate J. W., Ludlam C. A., Bruin T. No effect of aspirin on β-thromboglobulin plasma levels in healthy volunteers. Thromb. Res. 1980; 19: 257
- Ingerman-Wojenski C M., Smith J. B., Silver M. J. Difficulty in detecting inhibition of platelet aggregation by the impedance method. Thromb. Res. 1982; 28: 427
- Kelton J. G. Antiplatelet agents: rationale and results. Clin. Haematol. 1983; 12: 311
- Lowe G. D.O. Laboratory evaluation of hypercoagulability. Clin. Haematol. 1981; 10: 407
- O'Brien J. R. Effects of salicylates on human platelets. Lancet 1968; i: 779
- O'Brien J. R. Platelets and the vessel wall: how much aspirin?. Lancet 1980; i: 371
- Pagnan A., Faggiotto A., Bulian I., Visona A., Palu C. D. Abnormal platelet aggregation measured by screen filtration pressure (SFP) in coronary heart disease: a new risk factor?. Ada Cardiol. 1980; 6: 437
- Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. clin. Invest. 1982; 69: 1366
- Patrono C., Ciabattoni G., Pinca E., Pugliese F., Castrucci G., De Salvo A., Satta M. A., Peskar B. A. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb. Res. 1980; 17: 317
- Velaskar D. S., Chitre A. P. A new aspect of platelet aggregation and a test to measure it. Am. J. clin. Pathol. 1982; 77: 267
- Verstraete M. A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Haemostasis 1982; 12: 317
- Weksler B. B., Nachman R. L. Platelets and atherosclerosis. Am. J. Med. 1981; 71: 331
- Weksler B. B., Pett S. B., Alonso D., Richter R. C., Stelzer P., Subramanian V., Tack-Goldman K., Gay W. A. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N. Engl. J. Med. 1983; 308: 800
- Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; ii: 924